Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    [edited by] Mario E. Lacouture.
    Contents:
    Section 1 Dermotology and Oncology 1 Epidemiology and Burden of Disease / Beth N. McLellan, Devika Patel and Mario E. Lacouture
    2 The History of Supportive Oncodermatology / Yevgeniy Balagula, Steven T. Rosen and Mario E. Lacouture
    3 Structure and Function of the Integumentary System and the Dermatology Lexicon / Emmy Garber and Amit Garg
    Types of dermatologic reactions / Raed O. Alhusayen, Sandra R. Knowles and Neil H. Shear
    5 Grading Dermatologic Adverse Events on Clinical Trials using CTCAE v4.0 / Alice Chen, Asha Acharya and Ann Setser
    6 Psychosocial Issues in Oncology: Clinical management of psychosocial distress, health-related quality of life and special considerations in dermatologic oncology / Lynne I. Wagner and David Cella
    7 Dermatopathology / Molly A. Hinshaw and James L. Troy
    Section 2 8 Cancer-Related Dermatologic Disorders pareneoplastic, Inherited Cancer Syndrome, and Environmental Carcinogen-related Dermatoses / Cindy England Owen and Jeffrey P. Callen
    Section 3 Dermatologic Conditions During Cancer Therapy 9 Oral Mucosal Complications of Cancer Therapy / Stephen T. Sonis
    10 Hair Disorders Associated with Anticancer Agents / Caroline Yeager and Elise A. Olsen
    11 Nail Abnormalities in Oncology Practice / Robert Baran, Bernard Fouilloux and Caroline Robert
    12 Pruritus / Tejesh Patel and Gil Yosipovitch
    13 Management Options for Hot Flashes in Cancer Patients / Amanda R. Moraska and Charles L. Loprinzi
    Section 4 Skin toxicities due to chemotherapy 14 Alkylating agents / Elisabeth Livingstone, Lisa Zimmer, Larissa Schottler, Dirk Schadendorf
    15 Antimetabolite Reactions / Emily Y. Chu and Heidi H. Kong
    16 Topoisomerase-interacting agents / Tomas Skacel, Roger von Moos and Reinhard Dummer
    17 Epidermal Growth Factor Receptor Inhibitor Reactions / Yevgeniy Balagula and Mario E. Lacouture
    18 Small Molecule Kinase Inhibitors / Caroline Robert, Vincent Sibaud and Christine Mateus
    19 Antimicrotubule agents / Claus Garbe
    20 Histone Deacetylase Inhibitors, Proteasome inhibitors, Demethylating Agents, Arsenicals Retinoids / Najla Al-Dawsari, Shannon C. Trotter and Francine Foss
    21 Miscellaneous Reactions / Katharina C. Kaehler, Christine B. Boers-Doets, Mario E. Lacouture and Axel Hauschild
    22 Skin toxicities due to Biotherapy / Kathryn T. Ciccolini, Katherina C. Kaehler, Mario E. Lacouture and Axel Hauschild
    23 Monoclonal antibodies / Caroline Robert
    24 Endocrine Agents / Katherine Szyfelbein Masterpol, Maura Dickler and Mario Lacouture
    25 Agents for the management of hematologic reactions / Mee-young Lee and Caroline C. Kim
    26 Radiation-Induced Skin Reactions / Rebecca Wong and Zahra Kassam
    27 Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease / Stephanie Hu and Jonathan Cotliar
    28 Extravasation Reactions / Seppo W. Langer
    29 Topical Anticancer Therapies / Patricia L. Myskowski
    30 Life-threatening (Serious) Dermatologic Adverse Events / Milan J. Anadkat
    31 Dermatologic infections / Yevgeniy Balagula, Mario E. Lacouture and James I. Ito Section 5 Late Cutaneous Events from Cancer Treatments
    32 Late Dermatologic Conditions / Jennifer Namchoi Section 6 Dermatologic Practice in Oncology 33 Management Algorithms for Dermatologic Adverse Events / Alyx Rosen, Iris Amitay-Laish and Mario E. Lacouture
    34 Dermatological therapeutics and formulations / Judy H. Borovicka, Jennifer R.S. Gordon, Ann Cameron Haley, Nicole E. Larson and Dennis P. West 35 Dermatological Techniques and Procedures / Robert Eilers Jr., Kishwer S. Nehal and Erica H. Lee
    36 Appearance-Related Concerns in the Cancer Patient / Amy J. Derick.
    Digital Access Wiley 2014
  • Article
    Ohta T, Okuda S, Takahashi H.
    Biochim Biophys Acta. 1977 Apr 01;466(1):44-56.
    Cells of Escherichia coli were incubated in broth medium in the presence of 5 mM of hydroxylamine which completely inhibited growth but did not affect viabilities. Hydroxylamine is known to inhibit phosphatidylserine decarboxylase. A large amount of phosphatidylserine (up to 20% of total phospholipids), which did not occur in normal cells, accumulated accompanied with a decrease in phosphatidylethanolamine. Higher uptake activities of serine and glutamate were observed with the hydroxylamine-treated cells than control cells. When membrane vesicles from hydroxylamine-treated cells were prepared, they also displayed higher uptake activities of serine, proline, glutamate, and threonine than those of normal membranes. When hydroxylamine-treated cells were incubated with chloramphenicol, at concentrations which almost completely inhibited protein synthesis, the composition of phosphatidylserine decreased with a concomitant increase in that of phosphatidylethanolamine. The phospholipid composition of these cells incubated for 5 h with chloramphenicol became almost normal. Membranes vesicles prepared from such cells displayed reduced uptake activities, which were close to those of normal vesicles. These results were interpreted as indicating the altered transport activities due to the altered phospholipid composition.
    Digital Access Access Options